Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

Conditions:   Brain and Central Nervous System Tumors;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Metastatic Cancer;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Precancerous Condition;   Secondary Myelofibrosis;   Unspecified Adult Solid Tumor, Protocol SpecificIntervention:   Drug: PemetrexedSponsors:   Northwestern University;   National Cancer Institute (NCI)Active, not recruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials